|
|
FibroGen Announces Chinese State FDA Approval of Phase 1 and 2 Development of ... - PharmaLive.com (press release) |
|
PharmaLive.com (press release)In addition, at that time there was a limited health insurance system in China, so provision of care for ESRD patients, including dialysis and anemia ... |
|
|
FDA panel unanimously recommends approval for dabigatran - Cardiology Today |
|
Cardiology TodayThe FDA's Cardiovascular and Renal Drugs Advisory Committee has voted 9-0 for approval of the investigational anticoagulant dabigatran, according to a press ...FDA Committee Unanimously Supports Boehringer Ingelheim's Stroke-Prevention ... |
|
Mobile dialysis unit arrives in town without anyone to run it - Edmonton Journal |
|
Edmonton JournalEDMONTON - A $2-million mobile dialysis bus that was supposed to bring relief to patients in ... |
|
Immatics Raises Nearly €54M to Take Lead Therapeutic Cancer Vaccine into Phase III - Genetic Engineering News |
|
Genetic Engineering NewsLead product IMA901 comprises 10 TUMAPs that immatics clams are frequently found to be over-expressed in patients suffering from renal cell carcinoma. ...immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic ... |
|
Bioconnect Systems Gains CE Mark Approval for Optiflow Anastomotic System - Business Wire (press release) |
|
Business Wire (press release)Early clinical experience suggests the Optiflow may improve patient outcomes for dialysis access.” Adam Dakin, Bioconnect's President & CEO, added, ... |
|
|
|
|
<< Start < Prev 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 Next > End >>
|
|
Page 1303 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
